DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
VANCOUVER, British Columbia, Jan. 12, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) is pleased to announce that, on a vote by ballot, the six incumbent directors of the Company were re-elected at the Company’s annual general meeting held on January 8, 2016 (the “Meeting”).
Detailed results of the vote for the election of directors are as follows:
| Nominee | Votes For | % | Votes Withheld | % |
| Jason M. Aryeh | 30,993,845 | 90.32 | 3,321,352 | 9.68 |
| Dr. Geoffrey F. Cox, Ph.D | 31,208,904 | 90.95 | 3,106,293 | 9.05 |
| Dr. John W. Kozarich, Ph.D | 31,223,945 | 90.99 | 3,091,252 | 9.01 |
| Jeffrey A. Meckler | 30,811,599 | 89.79 | 3,503,598 | 10.21 |
| Dr. Stephen L. Sabba, M.D. | 31,202,781 | 90.93 | 3,112,416 | 9.07 |
| John C. Thomas, Jr. | 30,971,911 | 90.26 | 3,343,286 | 9.74 |
Final voting results on all matters voted on at the Meeting will be filed on SEDAR at www.sedar.com and EDGAR at www.sec.gov.
About QLT
QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases.
QLT’s head office is based in Vancouver, Canada and the Company is publicly traded on NASDAQ Stock Market (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT). For more information about the Company’s products and developments, please visit our web site at www.qltinc.com.
QLT Inc. Contacts: For Investors: Andrea Rabney or David Pitts Argot Partners P: 212-600-1902 [email protected] [email protected]
